[Intravitreal triamcinolone for diabetic macular oedema. Method and complications].
Macular edema is the first cause of visual impairment in diabetic population. The gold standard for diabetic macular edema is macular laser photocoagulation, the benefit of which was demonstrated in the Early Diabetic Retinopathy Study (ETDRS). In recent years, many clinical and experimental studies demonstrated that intravitreal injection of triamcinolone acetonide is a therapeutic option for treating diabetic macular edema.
Zamfir
Cristina
C
Institutul National De Diabet Prof. Dr. N. Paulescu Bucuresti. zamfir_cristina06@yahoo.com
D003930:Diabetic Retinopathy / Q000150:complications* / Q000188:drug therapy*; D005938:Glucocorticoids / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D008269:Macular Edema / Q000188:drug therapy* / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology; D008845:Microinjections; D016896:Treatment Outcome; D014222:Triamcinolone Acetonide / Q000008:administration & dosage* / Q000009:adverse effects
D005938:Glucocorticoids; D014222:Triamcinolone Acetonide